top of page
News
Chat
Insights
Portfolios
Education
About
Plans/Pricing
API/MCP
Finally, Therapeutics that slow Alzheimer’s...
But, which is the best?
Jul 16, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
Jan 4, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary:
Jan 4, 2023
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
